Location · Overland Park, KS
Clinical trials in Overland Park, KS
41 recruiting studies have a site in Overland Park, and 11 of them accept healthy volunteers.
41 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1
Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 4Overnight stay mentioned
Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users
Viatris Inc.
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants
Deciphera Pharmaceuticals, LLC
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Atea Pharmaceuticals, Inc.
- Location
- Overland Park, KS + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers
Antidote Therapeutics, Inc
- Location
- Overland Park, KS
- Eligibility basics
- Ages 23–59
- RecruitingHealthy volunteersPhase 1
First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Overland Park, KS
- Eligibility basics
- Ages 18–59
- RecruitingHealthy volunteers
Abuse Liability for Five Modern Oral Nicotine Products
RAI Services Company
- Location
- Overland Park, KS
- Eligibility basics
- Ages 21–60
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Overland Park, KS + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Vima Therapeutics
- Location
- Overland Park, KS + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor
AbbVie
- Location
- Overland Park, KS + 17 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- Overland Park, KS + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Ambros Therapeutics, Inc.
- Location
- Overland Park, KS + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Overland Park, KS + 111 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
Pfizer
- Location
- Overland Park, KS + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- Overland Park, KS + 80 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus
Novartis Pharmaceuticals
- Location
- Overland Park, KS + 14 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Eli Lilly and Company
- Location
- Overland Park, KS + 28 other US sites
- Eligibility basics
- Ages 12+
- Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Biosense Webster, Inc.
- Location
- Overland Park, KS + 22 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Crystalys Therapeutics
- Location
- Overland Park, KS + 81 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Crystalys Therapeutics
- Location
- Overland Park, KS + 82 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Intra-Cellular Therapies, Inc.
- Location
- Overland Park, KS + 19 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
ReGelTec, Inc.
- Location
- Overland Park, KS + 13 other US sites
- Eligibility basics
- Ages 22–85
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Overland Park, KS + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Incyte Corporation
- Location
- Overland Park, KS + 65 other US sites
- Eligibility basics
- Ages 2–11